Molecular Partners AG
MOLN4.380USD
-0.010-0.23%
收盘 12/22, 16:00（美东）报价延迟15分钟
163.81M总市值
亏损市盈率 TTM
关于 Molecular Partners AG 公司
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Molecular Partners AG简介
公司代码MOLN
公司名称Molecular Partners AG
上市日期Oct 22, 2014
CEOAmstutz (Patrick)
员工数量159
证券类型Depository Receipt
年结日Oct 22
公司地址Wagistrasse 14
城市SCHLIEREN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Switzerland
邮编8952
电话41447557700
网址https://www.molecularpartners.com/
公司代码MOLN
上市日期Oct 22, 2014
CEOAmstutz (Patrick)
Molecular Partners AG公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Renate Gloggner
Ms. Renate Gloggner
Executive Vice President - People and Community, Member of the Management Board
Executive Vice President - People and Community, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Alexander Zuercher
Mr. Alexander Zuercher
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
Switzerland
4.97M
0.00%
United States
0.00
0.00%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 8月17日 周日
更新时间: 8月17日 周日
持股股东
股东类型
持股股东
持股股东
占比
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
UBS Financial Services, Inc.
0.01%
其他
90.43%
持股股东
持股股东
占比
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
UBS Financial Services, Inc.
0.01%
其他
90.43%
股东类型
持股股东
占比
Hedge Fund
9.56%
Investment Advisor
0.01%
其他
90.42%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
15
3.59M
9.59%
-23.51K
2025Q2
16
3.58M
9.72%
-44.38K
2025Q1
16
3.58M
9.72%
-44.38K
2024Q4
16
3.58M
10.80%
+1.75M
2024Q3
19
850.31K
2.56%
-138.97K
2024Q2
20
861.27K
2.60%
-213.87K
2024Q1
22
946.77K
2.88%
-611.83K
2023Q4
26
957.56K
2.63%
-624.65K
2023Q3
28
961.52K
2.93%
-686.56K
2023Q2
36
934.21K
2.85%
-1.24M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Suvretta Capital Management, LLC
2.22M
6.03%
--
--
Jun 30, 2025
BVF Partners L.P.
1.35M
3.67%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
10.20K
0.03%
+3.85K
+60.59%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.07K
0%
--
--
Aug 31, 2025
Morgan Stanley & Co. LLC
367.00
0%
--
--
Jun 30, 2025
EverSource Wealth Advisors, LLC
41.00
0%
+41.00
--
Jun 30, 2025
BofA Global Research (US)
157.00
0%
--
--
Jun 30, 2025
Rhumbline Advisers Ltd. Partnership
--
0%
-269.00
-100.00%
Jun 30, 2025
Qube Research & Technologies Ltd
--
0%
-16.00
-100.00%
Sep 30, 2024
Old Mission Capital LLC
--
0%
-10.37K
-100.00%
Sep 30, 2024
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Molecular Partners AG的前五大股东是谁？
Molecular Partners AG 的前五大股东如下：
Suvretta Capital Management, LLC持有股份：2.22M，占总股份比例：6.03%。
BVF Partners L.P.持有股份：1.35M，占总股份比例：3.67%。
UBS Financial Services, Inc.持有股份：10.20K，占总股份比例：0.03%。
Geode Capital Management, L.L.C.持有股份：1.07K，占总股份比例：0.00%。
Morgan Stanley & Co. LLC持有股份：367.00，占总股份比例：0.00%。
Suvretta Capital Management, LLC持有股份：2.22M，占总股份比例：6.03%。
BVF Partners L.P.持有股份：1.35M，占总股份比例：3.67%。
UBS Financial Services, Inc.持有股份：10.20K，占总股份比例：0.03%。
Geode Capital Management, L.L.C.持有股份：1.07K，占总股份比例：0.00%。
Morgan Stanley & Co. LLC持有股份：367.00，占总股份比例：0.00%。
Molecular Partners AG的前三大股东类型是什么？
Molecular Partners AG 的前三大股东类型分别是：
Suvretta Capital Management, LLC
BVF Partners L.P.
UBS Financial Services, Inc.
Suvretta Capital Management, LLC
BVF Partners L.P.
UBS Financial Services, Inc.
有多少机构持有Molecular Partners AG(MOLN)的股份？
截至2025Q3，共有15家机构持有Molecular Partners AG的股份，合计持有的股份价值约为3.59M，占公司总股份的9.59%。与2025Q2相比，机构持股有所增加，增幅为-0.13%。
哪个业务部门对Molecular Partners AG的收入贡献最大？
在FY2024，--业务部门对Molecular Partners AG的收入贡献最大，创收--，占总收入的--%。
